Metabolic myopathy: Difference between revisions
CSV import |
CSV import |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
<gallery> | |||
File:Hydrolysis_of_ATP.png|Hydrolysis of ATP | |||
File:1008_Skeletal_Muscle_Contraction.jpg|Skeletal Muscle Contraction | |||
</gallery> | |||
Revision as of 01:36, 18 February 2025
Metabolic Myopathy is a group of metabolic disorders that primarily affect the muscles. These disorders are caused by defects in the processing of nutrients within the body, leading to a range of symptoms including muscle weakness, cramps, and in severe cases, rhabdomyolysis.
Causes
Metabolic myopathies are caused by genetic mutations that lead to deficiencies in the enzymes needed for muscle energy production. These enzymes are involved in the breakdown of carbohydrates and fats, the primary sources of energy for muscle cells. The specific enzyme deficiency determines the type of metabolic myopathy, such as McArdle's disease, CPT II deficiency, and mitochondrial myopathies.
Symptoms
The symptoms of metabolic myopathies vary depending on the specific disorder and the severity of the enzyme deficiency. Common symptoms include muscle weakness, fatigue, muscle cramps, and exercise intolerance. In severe cases, patients may experience rhabdomyolysis, a condition characterized by the breakdown of muscle tissue leading to the release of muscle fiber contents into the bloodstream.
Diagnosis
Diagnosis of metabolic myopathies involves a combination of clinical evaluation, laboratory testing, and genetic testing. Muscle biopsies may also be performed to examine the muscle tissue for signs of metabolic disease.
Treatment
Treatment for metabolic myopathies is primarily supportive and focuses on managing symptoms and preventing complications. This may include dietary modifications, physical therapy, and in some cases, medication.


